More About The Prasad Adusumilli Lab Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.

Aurore Morello

Research Scholar

Office Phone

212-639-8158

Start Year

2013

Publications

Manuscripts

Abstracts/Presentations

  • Morello A, Chen N, Cherkassky L, Sadelain M, Jones DR, Adusumilli PS. Converting tumor-mediated PD-L1 inhibition into CAR T-cell costimulation to potentiate thoracic cancers immunotherapy. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Morello A, Zeltsman M, Bograd A, Jones DR, Adusumilli PS. Mechanistic insights into CAR T-cell efficacy in the treatment of heterogenous antigen expressing lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Morello A, Villena-Vargas J, Mayor M, Bograd AJ, Jones DR, Sadelain M,  Adusumilli PS. Mesothelin-Targeted CAR T-Cell Therapy for the Treatment of Heterogeneous Antigen-Expressing Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Mayor M, Villena-Vargas J, de Biasi A, Morello A, Jones DR, Sadelain M, Adusumilli PS. Tumor-Targeted Radiation Therapy Helps Overcome the Solid Tumor T-Cell Infiltration Barrier and Promotes Mesothelin CAR T-Cell Therapy. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Ujiie H, Morello A, Kadota K, Buitrago DH, Woo K, Jones DR, Travis WD, Sadelain M, Adusumilli PS. Mesothelin and MUC16 (CA125) Are Antigen-Targets for CAR T-Cell Therapy in Primary and Metastatic Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Cherkassky L, Morello A, Villena-Vargas J, Mayor M, Jones DR, Sadelain M, Adusumilli PS. Genetic-Engineering Strategies to Enhance CAR T-Cell Therapy Efficacy against PD-L1 Expressing Lung Adenocarcinoma and Mesothelioma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Roldan C, Morello A, Adusumilli PS. Immunotherapeutic T-cell engineering techniques targeting solid tumors. 37th Annual Memorial Sloan-Kettering Cancer Center Medical Student Summer Fellowship Program Poster Presentation. August 14, 2014; New York, NY.